- Pelareorep plus checkpoint inhibitor more than doubled ORR and extended median duration of response by 50% vs standard of care in 2L+ SCAC.
- 4 of 6 patients with HPV-16 clonal expansion demonstrated tumor shrinkage.
- Translational data presented at SITC 2026 confirms immune activation in tumor microenvironment.
Signal #130416 · SEC 8-K
$ONCY SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $ONCY filing catalyst
Why did $ONCY trigger an AI stock catalyst alert?
$ONCY triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +4.5/10). Headline: Oncolytics Biotech Reports Positive Pelareorep Data in HPV-Driven Anal Cancer. Key points: - Pelareorep plus checkpoint inhibitor more than doubled ORR and extended median duration of response by 50% vs standard of care in 2L+ SCAC. - 4 of 6 patients with HPV-16 clonal expansion demonstrated tumor shrinkage. - Translational data presented at SITC 2026 confirms immune activation in tumor microenvironment.
How did $ONCY stock react after the SEC filing?
After the SEC 8-K for $ONCY, observed market reaction: T0 price $0.41. Past moves do not guarantee future results.
Where can I get real-time $ONCY SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $ONCY via Telegram and the VIP Web Terminal from €10/month.